Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Schechter

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Journal of the International AIDS Society|November 14, 2014
Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infectionJohn Thornhill, Jamie Inshaw, Soonita Oomeer, et al.
Bulletin of the World Health Organization|August 2, 2008
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countriesMartin W G Brinkhof, François Dabis, Landon Myer, et al.
Antiviral Therapy|April 8, 2017
Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, CameroonCatherine A Hankins, Sinata Koulla-Shiro, Peter Kilmarx, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|March 17, 2010
Risk-based assessment does not distinguish between recent and chronic HIV-1 infection in Rio de Janeiro, BrazilMonica Merçon, Suely H Tuboi, Sônia Maria Batista, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 12, 2009
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the CaribbeanSuely H Tuboi, Mauro Schechter, Catherine C McGowan, et al.
American Journal of Epidemiology|October 14, 2008
Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in BrazilAntonio G Pacheco, Valeria Saraceni, Suely H Tuboi, et al.
Open Forum Infectious Diseases|January 9, 2018
Systemic Inflammation, Coagulation, and Clinical Risk in the START TrialJason V Baker, Shweta Sharma, Birgit Grund, et al.
AIDS and Behavior|April 30, 2016
The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE StudyMegha L Mehrotra, David V Glidden, Vanessa McMahan, et al.
International Journal of STD & AIDS|July 6, 2006
Assessing sexually transmitted infections in a cohort of women living with HIV/AIDS, in Rio de Janeiro, BrazilBeatriz Grinsztejn, Francisco Inácio Bastos, Valdiléa G Veloso, et al.
The Lancet. HIV|September 24, 2016
Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort studyMonica Gandhi, David V Glidden, Kenneth Mayer, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Journal of the International AIDS Society|November 14, 2014
Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infectionJohn Thornhill, Jamie Inshaw, Soonita Oomeer, et al.
Bulletin of the World Health Organization|August 2, 2008
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countriesMartin W G Brinkhof, François Dabis, Landon Myer, et al.
Antiviral Therapy|April 8, 2017
Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, CameroonCatherine A Hankins, Sinata Koulla-Shiro, Peter Kilmarx, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|March 17, 2010
Risk-based assessment does not distinguish between recent and chronic HIV-1 infection in Rio de Janeiro, BrazilMonica Merçon, Suely H Tuboi, Sônia Maria Batista, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 12, 2009
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the CaribbeanSuely H Tuboi, Mauro Schechter, Catherine C McGowan, et al.
American Journal of Epidemiology|October 14, 2008
Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in BrazilAntonio G Pacheco, Valeria Saraceni, Suely H Tuboi, et al.
Open Forum Infectious Diseases|January 9, 2018
Systemic Inflammation, Coagulation, and Clinical Risk in the START TrialJason V Baker, Shweta Sharma, Birgit Grund, et al.
AIDS and Behavior|April 30, 2016
The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE StudyMegha L Mehrotra, David V Glidden, Vanessa McMahan, et al.
International Journal of STD & AIDS|July 6, 2006
Assessing sexually transmitted infections in a cohort of women living with HIV/AIDS, in Rio de Janeiro, BrazilBeatriz Grinsztejn, Francisco Inácio Bastos, Valdiléa G Veloso, et al.
The Lancet. HIV|September 24, 2016
Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort studyMonica Gandhi, David V Glidden, Kenneth Mayer, et al.
Pageof 12